Clinical Trial Update: HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating de-intensified hypofractionated radiation therapy for HPV-associated oropharyngeal cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-associated Oropharyngeal Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Human Papillomavirus-Related Carcinoma, Oropharyngeal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2025-12-15